Research Article
1 October 2007

The Essential tacF Gene Is Responsible for the Choline-Dependent Growth Phenotype of Streptococcus pneumoniae

ABSTRACT

Streptococcus pneumoniae has an absolute nutritional requirement for choline, and the choline molecules are known to incorporate exclusively into the cell wall and membrane teichoic acids of the bacterium. We describe here the isolation of a mutant of strain R6 in which a single G→T point mutation in the gene tacF (formerly designated spr1150) is responsible for generating a choline-independent phenotype. The choline-independent phenotype could be transferred to the laboratory strain R6 and to the encapsulated strain D39 by genetic transformation with a PCR product or with a plasmid carrying the mutated tacF gene. The tacF gene product belongs to the protein family of polysaccharide transmembrane transporters (flippases). A model is presented in which TacF is required for the transport of the teichoic acid subunits across the cytoplasmic membrane. According to this model, wild-type TacF has a strict specificity for choline-containing subunits, whereas the TacF present in the choline-independent mutant strain is able to transport both choline-containing and choline-free teichoic acid chains. The proposed transport specificity of parental-type TacF for choline-containing subunits would ensure the loading of the cell wall with teichoic acid chains decorated with choline residues, which appear to be essential for the virulence of this pathogen.
One of the unique properties of the human pathogen Streptococcus pneumoniae is the strict nutritional requirement for choline (18), which is taken up from the growth medium and metabolized exclusively to be attached to the wall teichoic acid and the lipoteichoic acid (25). The choline residues of the teichoic acid are involved in a wide variety of physiological functions, including the activation of the murein (peptidoglycan) hydrolases LytA, LytB, and LytC (8, 9, 11, 17), the binding of a class of surface proteins (the choline-binding proteins) (20, 29), and the interaction with bacteriophages (15) and host proteins, for example, with the receptor for the platelet-activating factor (5). The essentiality of choline residues for pneumococcal virulence recently has been demonstrated (13).
Choline is transported into the cytoplasm and is activated to CDP-choline by the products of the licABC genes (2, 3). CDP-choline is the substrate of proteins (presumably the products of the licD1 and licD2 genes) that attach the phosphoryl choline residues to the teichoic acid precursors (30). These genes are clustered in the lic region on the pneumococcal chromosome, which contains three additional genes, spr1148, spr1149, and spr1150, of unknown functions. Based on sequence comparisons, it was suggested that these genes may encode an alcohol dehydrogenase (spr1148), a CDP-ribitol pyrophosphorylase (spr1149), and a sugar transporter (spr1150) (30).
Although the cell wall choline residues are of great importance for the physiology of S. pneumoniae, none of the choline-related functions is essential for cell growth, and the molecular mechanism(s) responsible for the choline dependency of pneumococcal growth has remained unknown. Until now, two choline-independent mutant strains of S. pneumoniae have been reported. Mutant R6Cho was obtained with a background of S. pneumoniae strain R6 from a heterologous genetic cross with DNA from Streptococcus oralis, which has a choline-containing cell wall but, unlike S. pneumoniae, is able to grow in the absence of exogenous choline (22). A second mutant, JY2190, was obtained after successive growth of S. pneumoniae strain Rx1 in medium without choline but with decreasing concentrations of ethanolamine (28). It is currently unknown which genetic change(s) is responsible for the choline-independent phenotype of these two mutants.
In this communication, we describe a third choline-independent mutant, R6Chi, which was obtained with a background of S. pneumoniae strain R6. The method of isolation was similar to the one used for the isolation of mutant JY2190 of strain Rx1: cultures of strain R6 were grown in chemically defined medium in which the choline component was replaced by gradually decreasing concentrations of ethanolamine and eventually by no aminoalcohol at all. We have identified a single-point mutation residing in the so-far uncharacterized gene spr1150 (which we rename tacF), which appears to be responsible for the choline independence of R6Chi. We present a model for the physiological function of TacF and for the mechanism of the pneumococcal nutritional requirement for choline.

MATERIALS AND METHODS

Strains and growth conditions.

S. pneumoniae D39 and R6 (27) were grown at 37°C in Cden medium (26) with 5 μg/ml of choline or in complex C+Y medium containing 1 mg/ml yeast extract (12). Cden agar plates contained 1.5% agar. Growth on Cden agar plates was documented after they were replica plated on nitrocellulose filters, followed by staining with 0.1% amido black solution (45% methanol, 10% acetic acid) and destaining with water. Competent pneumococci were obtained as previously described (14), with the addition of competence peptide (16). Escherichia coli DH5α (10) was grown in Luria broth at 37°C with aeration. If necessary, erythromycin was added at a concentration of 1 mg/ml for E. coli and 1 μg/ml for S. pneumoniae.

Generation of a choline-independent mutant.

R6 was grown sequentially at 37°C in Cden medium lacking choline but containing decreasing concentrations of ethanolamine (200, 20, 2, 0.2, and 0 μg/ml) as described previously (28). The culture then was plated on tryptic soy broth containing 3% sheep blood. One clone capable of growing in the absence of choline in the growth medium was named R6Chi. 1H and 31P nuclear magnetic resonance analyses of isolated cell walls confirmed the absence of phosphorylcholine residues in R6Chi grown in the absence of choline.

Generation of R6pJDC1150M, R6pJDC1150, R6Chip, and D39Chip.

The plasmids pJDC1150 and pJDC1150M were constructed to transfer the tacF gene to pneumococcal strains by insertion duplication mutagenesis. For this, the tacF region (positions 1151093 to 1153039) was amplified by PCR with the primers 5′-CCATGCGAGCTCCATAAAAGAAATACTGGTCC-3′ and 5′-TATGTCGGATCCACAGATCAATATCGTCGTCC-3′, using chromosomal DNA from R6Chi (for pJDC1150M) or from R6 (for pJDC1150). The PCR product was restricted with SacI and BamHI and ligated into plasmid pJDC9 (4), which was treated with the same restriction enzymes. pJDC1150M and pJDC1150 were transformed into R6 under selection for erythromycin to generate R6pJDC1150M and R6pJDC1150, respectively. The correct integration of pJDC1150M and pJDC1150 was confirmed by PCR analysis using the primer pairs 5′-ATTACGCCAAGCTTGCATGC-3′ and 5′-AAATAGGTCGATCACCTAGC-3′, 5′-CACGACGTTGTAAAACGACG-3′ and 5′-CGTTGGTAGTCTTCTCTAGG-3′, and 5′-AAAGGGCATTTAACGACGAAACTGG-3′ and 5′-GACAATACTTGCTCATAAGTAACGG-3′. The PCRs with chromosomal DNA from R6pJDC1150M and R6pJDC1150 (but not from R6) yielded products of the expected sizes, covering both boundaries of the plasmid integration site as well as an internal fragment of the erythromycin resistance gene on pJDC9. The choline-independent strains R6Chip and D39Chip were generated by transforming the respective parental strains (R6 and D39) with a PCR product covering the tacF region (see above) and selection on choline-free Cden agar plates.

Inactivation of lic genes.

The licA, licB, and licC genes were inactivated in R6Chi and D39Chi with the help of pJDC9-based plasmids containing internal sequences of the genes to be inactivated, as described before (13). Inactivation of licA most likely has polar effects on the expression of licB and licC. All three lic mutants are unable to utilize exogenous choline. Therefore, an inactivation of these lic genes is possible only in choline-independent mutant strains.

Intraperitoneal mouse virulence model.

Strains D39Chip and D39ChiplicB31 were grown in C+Y medium to an optical density at 590 nm of 0.6, cells were resuspended in pyrogen-free 0.9% sodium chloride solution, and 10-fold serial dilutions were prepared. Groups of 8-week-old female CD1 mice (5 mice per bacterial concentration) were injected (via the peritoneal cavity) with 0.5 ml of the inocula containing between 103 to 107 CFU. Mouse survival was monitored for 3 to 7 days.

Intranasal mouse colonization model.

Strains D39Chip, D39ChiplicA65, D39ChiplicB31, and D39ChiplicC112 were grown to an optical density at 590 nm of 0.6 and were centrifuged to pellet bacterial cells. Bacteria were resuspended in pyrogen-free saline (0.9% NaCl) to obtain a bacterial concentration of 108 CFU/ml. Groups of 8-week-old CD1 female mice (10 per strain) were anesthetized using a xylazine and ketamine mixture (75 μl injected into the peritoneal cavity), as described by Kharat and Tomasz (13). Suspensions of bacteria (10 μl) were inoculated through the nostrils with a 10-μl blunt-end Hamilton syringe. Mice were sacrificed 48 h after inoculation by injection with 100 μl of Nembutal into the peritoneal cavity. Bacteria colonizing the nasopharynx were collected by expelling 50 μl saline solution through the trachea and were enumerated on blood agar plates supplemented with 5 μg/ml gentamicin.

Other methods.

DNA sequencing of PCR products and plasmids was done with the help of custom-made oligonucleotides (http://biomers.net/default.aspx ) at 4BaseLab, Reutlingen, Germany. The isolation of chromosomal DNA and of plasmids, PCR and purification of PCR products, and separation of DNA in agarose gels were done according to standard procedures described previously (21). Bacterial cells were visualized by light microscopy using a 40× objective.

RESULTS

Identification of a point mutation in the spr1150 gene of R6Chi.

The choline-independent mutant R6Chi was isolated as described in Materials and Methods. Several genes with known or hypothetical functions in pneumococcal cell wall metabolism were sequenced from R6Chi and from its parental strain, R6. The obtained sequences were compared to the corresponding sequences of strains TIGR4 and R6 in the public databases. A single-point mutation, a T replacing a G at position 1152062, was identified in the chromosomal region of bp 1150093 to 1153021 of mutant R6Chi. The mutation was identified to reside at position 700 in the hypothetical spr1150 gene, and it was absent from the sequence determined from chromosomal DNA of the parental strain, R6 (Fig. 1).

The point mutation in spr1150 is responsible for the choline-independent phenotype.

The chromosomal region from 261 bp upstream to 179 bp downstream of spr1150 (bp 1151093 to 1153039) from R6Chi or from R6 was cloned into plasmid pJDC9, resulting in the plasmid pJDC1150M or pJDC1150, respectively. Upon transformation into R6 and selection for resistance to erythromycin, the plasmids integrated into the chromosome, leading to strains R6pJDC1150M and R6pJDC1150. R6pJDC1150M carries a wild-type and a mutated copy of spr1150, whereas R6pJDC1150 carries two copies of the wild-type spr1150 (Fig. 1). R6pJDC1150M, but not R6pJDC1150, was able to grow in the absence of exogenous choline in liquid medium and on agar plates (Fig. 2). In another genetic experiment, the product of the PCR amplification of the spr1150 region of R6Chi was directly transformed into R6 or into the encapsulated D39 strain with selection on choline-free Cden plates. Choline-independent transformants with the mutated spr1150 gene were obtained, and one clone of each transformation experiment was isolated and named R6Chip and D39Chip, respectively.
These results prove that the G700→T mutation in spr1150 enables pneumococci to grow in the absence of exogenous choline. Furthermore, the mutated spr1150 gene is dominant and renders pneumococci choline independent in the presence of the unmutated spr1150 gene.

Hypothetical function of Spr1150.

The spr1150 gene is located in the lic region, which includes three genes for choline uptake and activation (licA, licB, and licC), two genes (licD1 and licD2) presumably involved with the incorporation of choline into teichoic acid precursor, and three genes (spr1148, spr1149, and spr1150) of unknown function. The mutation in the spr1150 gene of R6Chi results in the replacement of the valine residue at position 234 of the derived amino acid sequence of the wild-type protein with a phenylalanine. Spr1150 has 14 predicted transmembrane helices (http://bp.nuap.nagoya-u.ac.jp/sosui/ ) and belongs to the protein family PF01943, which currently contains 1,132 integral membrane proteins, many of which are implicated in the production of polysaccharides (http://www.sanger.ac.uk/cgi-bin/Pfam/getacc?PF01943 ). Furthermore, Spr1150 is one of 113 proteins of the cluster of orthologous groups of proteins 2244 (COG2244) designated “membrane proteins involved in the export of O antigen and teichoic acid” (http://www.ncbi.nlm.nih.gov/COG/grace/wiew.cgi?COG2244 ) (24). Two members of COG2244 from E. coli have a proven transmembrane polysaccharide transport (flippase) function, the O-antigen flippase Wzx (RfbX) (1) and the lipid III flippase WzxE (19). Spr1150 may function as a flippase to transport the lipid-linked, choline-containing teichoic acid precursors across the cytoplasmic membrane in S. pneumoniae, and we propose to rename the spr1150 gene tacF (for teichoic acid flippase).

Growth characteristics of choline-independent strains carrying the mutated tacF gene.

All strains carrying a mutated tacF gene, R6Chi, R6Chip, D39Chip, and R6pJDC1150M, grew in long chains and did not autolyze in the stationary phase when grown in the absence of choline (Fig. 3). However, if choline was present in the growth medium, they grew as diplococci or as short chains and lysed in the stationary phase, indicating that the mutants have retained the capacity to incorporate choline into their cell walls. This growth behavior is similar to that described for the two previously reported choline-independent pneumococcal mutants (22, 28).

Effect of cell wall choline on pneumococcal virulence.

A recent study has demonstrated the drastic reduction in the virulence of a choline-independent capsular type 2 mutant strain derived from R6Cho in several models of pneumococcal disease (13). However, mutant R6Cho was obtained from a genetic cross in which S. oralis was the source of donor DNA (13). Thus, strain R6Cho may contain genetic elements from S. oralis, possibly affecting virulence. Therefore, it was important to repeat the virulence studies with a choline-independent strain free of heterologous genetic material. Choline-independent strain D39Chip, expressing a type 2 capsule, was constructed by transforming the PCR product of tacF from strain R6Chi. In order to prevent D39Chip from incorporating choline from the in vivo environment, one of the lic genes required for choline uptake and/or activation also was inactivated to produce a strain in which the impact of the choline-free cell wall could be tested in vivo for virulence (13). Inactivation of licA, licB, or licC in D39Chip resulted in mutants that grew in chains and did not autolyze in stationary phase, even in choline-containing semisynthetic medium. D39Chip (with intact licB) and D39ChiplicB31 (with inactivated licB) represent an isogenic pair of strains that differ in their ability to decorate the cell wall with choline. These strains were used in the mouse intraperitoneal model.
Mice injected with as few as 103 CFU of D39Chip caused death within 24 h, whereas mice injected with D39ChiplicB31 continued to exhibit 20% survival at the end of experiment, even when injected with a concentration of bacteria as high as 107 CFU (Fig. 4).

Mouse intranasal colonization by mutants lacking cell wall choline.

Strains D39Chip, D39ChiplicA65, D39ChiplicB31, and D39ChiplicC112 were grown in the choline-containing medium C+Y. Eight-week-old CD1 female mice (10 mice per strain) were anesthetized and inoculated with 10 μl bacterial suspension containing 108 CFU/ml in sterile saline. Mice inoculated with choline-deficient mutant bacteria failed to colonize, whereas mice inoculated with D39Chip showed bacterial loads as high as 300 to 500 per mouse.

DISCUSSION

Pneumococci are the only known bacterial species with the same, chemically complex structure in the repeating unit of their wall teichoic acid and lipoteichoic acid, both of which carry one or two choline residues per teichoic acid chain (7). Most genes required for the biosynthesis of the pneumococcal teichoic acids are unknown. The following observations indicate that the tacF gene has a role in teichoic biosynthesis. (i) The tacF gene is located in the lic gene cluster of the chromosome, adjacent to five known genes of choline metabolism. (ii) The mutation G700→T in the tacF gene described here annulled the nutritional requirement for choline.
The deduced integral membrane protein TacF belongs to the COG2244 group of proteins, members of which are confirmed or putative flippases involved in the transmembrane transport of lipid-linked carbohydrate subunits. Considering its link to the choline-dependent growth phenotype, we propose that TacF is the flippase for the transmembrane transport of the teichoic acid subunits. According to this model (Fig. 5A), the wild-type protein, TacF(V234), would have a strict specificity for transport of choline-containing subunits, whereas the mutant TacF(F234) flippase also would transport subunits without choline, which accumulate when choline-independent mutant cells grow in the absence of exogenous choline. This model predicts a dominant effect of the mutated tacF gene in the presence of the wild-type gene, as we have observed in R6pJDC1150M in this work. It is predicted that TacF has 14 transmembrane helices, with V234 being located on a loop region between the transmembrane helices 7 and 8. This loop might guard the transport channel to provide substrate specificity. In the absence of another homologous pneumococcal protein with the same role, the predicted teichoic acid transport function of TacF should be essential for pneumococcal cell wall biosynthesis and growth. Indeed, the tacF gene was among 133 genes identified as being essential in S. pneumoniae (23).
Our data indicate that tacF is the only component determining the choline requirement for growth, and it is likely that the choline-independent mutant JY2190, isolated by the same method from strain Rx1 (28), harbors a mutated tacF gene. Having a flippase with transport specificity for choline-containing teichoic acid subunits would be an elegant way for the cell to ensure the loading of the cell wall with choline residues, which are essential for many important physiological functions. By this mechanism, the subunits would remain at the inner leaflet of the cytoplasmic membrane until they are loaded with choline, a process that is catalyzed (presumably) by the cytoplasmic LicD1 and/or LicD2 enzyme, using CDP-choline as substrate.
Considering the proposed flippase function of TacF, there are several factors that could account for the choline dependency of growth in wild-type pneumococci. First, teichoic acids may be essential polymers of the cell wall, and the lack of transport of choline-free teichoic acid chains in strains carrying the wild-type tacF would be lethal for the cells. Second, the possible accumulation of lipid-linked, choline-free precursors in the inner leaflet of the cytoplasmic membrane could disrupt the membrane integrity. Finally, the accumulation of lipid-linked, choline-free precursors might trap the undecaprenyl phosphate transport lipid, which then is unavailable for the transport of precursor for the essential peptidoglycan (murein) synthesis. The latter possibility has been proposed before, because peptidoglycan synthesis was inhibited upon choline deprivation (6). The interconnection between teichoic acid and peptidoglycan synthesis and the resulting consequences for growth of wild-type and choline-independent mutants are shown in Fig. 5B to D.
The cell wall choline residues have a variety of physiological functions. In this communication, we have demonstrated the essential role of choline for pneumococcal virulence and colonization, fully confirming the findings already reported for the other choline-independent pneumococcal strain, R6cho, which harbors an unknown DNA sequence obtained from S. oralis in the heterologous genetic cross (13).
The proposed transport process of the choline-loaded teichoic acid precursors by the hypothetical flippase TacF may present a novel target for antimicrobial therapy against pneumococci.
FIG. 1.
FIG. 1. Organization of the lic region of the different strains used in this study. The base at position 700 of the spr1150 (tacF) gene is indicated. An asterisk indicates an inactivated licA gene. Divergent transcription of the choline utilization genes driven by promoters is denoted by a perpendicular arrow before spr1149 and spr1150, respectively. erm, erythromycin resistance gene present on the integration plasmid pJDC9. Phenotype abbreviations: D, choline-dependent growth; I, choline-independent growth; +, choline incorporation from the growth medium; −, no choline incorporation from the growth medium.
FIG. 2.
FIG. 2. Growth of the different strains on Cden plates with or without choline and erythromycin. Only the strains with the mutated tacF gene, R6Chi and R6pJDC1150M, are capable of growing in the absence of choline. Only the strains transformed with a pJDC9-based plasmid are resistant to erythromycin.
FIG. 3.
FIG. 3. Cells of R6Chi and R6pJDC1150M visualized by light microscopy. Both strains grew as diplococci, and they grew in short chains in the presence of choline and in long chains in the absence of choline. Bar, 10 μm.
FIG. 4.
FIG. 4. Virulence of choline-free S. pneumoniae in the mouse intraperitoneal model. Bacteria were injected into the intraperitoneal cavity at different cell concentrations, and the survival of mice was monitored for 3 to 7 days. Strain D39Chip was inoculated with 103 CFU/mouse (solid lines with solid squares), and strain D39ChiplicB31 (dashed lines and open symbols) was inoculated with the following concentrations (in CFU/mouse): 103 (open triangles), 105 (open circles), 106 (open diamonds), and 107 (open squares).
FIG. 5.
FIG. 5. Model for the specificity of the proposed TacF teichoic acid subunit flippase and for the choline-dependent growth phenotype. (A) The wild-type TacF(V234) flippase has a strict specificity for choline-containing teichoic acid subunits and does not transport subunits without choline, ensuring the loading of the cell wall with choline residues (left side). The TacF(F234) flippase, encoded by the mutated tacF gene in R6Chi, is able to transport both choline-containing and choline-free teichoic acid subunits. RU, repeating unit; PCho, phosphoryl choline; black bar, lipid anchor. (B) The membrane steps of teichoic acid and peptidoglycan biosynthesis pathways are interconnected by the undecaprenyl phosphate transport lipid (black rectangle), which is released in the diphosphate form during polymerization of the peptidoglycan (PG) and teichoic acid (TA) strands, respectively, and then is recycled for further cycles of subunit transport. (C) In the absence of choline, wild-type cells cannot produce teichoic acids because of the specificity of TacF for choline-loaded teichoic acid subunits. (D) The mutant strain R6Chi is able to grow in the absence of choline and to produce a choline-free cell wall, because the altered flippase (TacF*) has lost its specificity for choline-containing subunits.

Acknowledgments

This work was supported by the European Commission through the EUR-INTAFAR project (LSHM-CT-2004-512138 to W.V.) and by a grant from the Irene Diamond Foundation (to A.T.).
We thank Jean-Pierre Claverys for critical reading of the manuscript.

REFERENCES

1.
Alaimo, C., I. Catrein, L. Morf, C. L. Marolda, M. Callewaert, M. A. Valvano, M. F. Feldman, and M. Aebi. 2006. Two distinct but interchangeable mechanisms for flipping of lipid-linked oligosaccharides. EMBO J. 25 : 967-976.
2.
Bean, B., and A. Tomasz. 1977. Choline metabolism in pneumococci. J. Bacteriol. 130 : 571-574.
3.
Campbell, H. A., and C. Kent. 2001. The CTP:phosphocholine cytidylyltransferase encoded by the licC gene of Streptococcus pneumoniae: cloning, expression, purification, and characterization. Biochim. Biophys. Acta 1534 : 85-95.
4.
Chen, J. D., and D. A. Morrison. 1987. Cloning of Streptococcus pneumoniae DNA fragments in Escherichia coli requires vectors protected by strong transcriptional terminators. Gene 55 : 179-187.
5.
Cundell, D. R., N. P. Gerard, C. Gerard, I. Idanpaan-Heikkila, and E. I. Tuomanen. 1995. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 377 : 435-438.
6.
Fischer, H., and A. Tomasz. 1985. Peptidoglycan cross-linking and teichoic acid attachment in Streptococcus pneumoniae. J. Bacteriol. 163 : 46-54.
7.
Fischer, W. 1997. Pneumococcal lipoteichoic and teichoic acid. Microb. Drug Resist. 3 : 309-325.
8.
García, P., M. P. Gonzalez, E. Garcia, R. Lopez, and J. L. Garcia. 1999. LytB, a novel pneumococcal murein hydrolase essential for cell separation. Mol. Microbiol. 31 : 1275-1277.
9.
García, P., M. Paz Gonzalez, E. Garcia, J. L. Garcia, and R. Lopez. 1999. The molecular characterization of the first autolytic lysozyme of Streptococcus pneumoniae reveals evolutionary mobile domains. Mol. Microbiol. 33 : 128-138.
10.
Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166 : 557-580.
11.
Höltje, J. V., and A. Tomasz. 1975. Specific recognition of choline residues in the cell wall teichoic acid by the N-acetylmuramyl-l-alanine amidase of Pneumococcus. J. Biol. Chem. 250 : 6072-6076.
12.
Horne, D. S., and A. Tomasz. 1993. Possible role of a choline-containing teichoic acid in the maintenance of normal cell shape and physiology in Streptococcus oralis. J. Bacteriol. 175 : 1717-1722.
13.
Kharat, A. S., and A. Tomasz. 2006. Drastic reduction in the virulence of Streptococcus pneumoniae expressing type 2 capsular polysaccharide but lacking choline residues in the wall. Mol. Microbiol. 60 : 93-97.
14.
Lacks, S. 1966. Integration efficiency and genetic recombination in pneumococcal transformation. Genetics 53 : 207-235.
15.
Lopez, R., E. Garcia, P. Garcia, C. Ronda, and A. Tomasz. 1982. Choline-containing bacteriophage receptors in Streptococcus pneumoniae. J. Bacteriol. 151 : 1581-1590.
16.
Morrison, D. A. 1997. Streptococcal competence for genetic transformation: regulation by peptide pheromones. Microb. Drug Resist. 3 : 27-37.
17.
Mosser, J. L., and A. Tomasz. 1970. Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme. J. Biol. Chem. 245 : 287-298.
18.
Rane, L., and Y. Subbarow. 1940. Choline, panthothenic acid and nicotinic acid as essential growth factors for pneumococcus. J. Biol. Chem. 134 : 455-456.
19.
Rick, P. D., K. Barr, K. Sankaran, J. Kajimura, J. S. Rush, and C. J. Waechter. 2003. Evidence that the wzxE gene of Escherichia coli K12 encodes a protein involved in the transbilayer movement of a trisaccharide-lipid intermediate in the assembly of enterobacterial common antigen. J. Biol. Chem. 278 : 16534-16542.
20.
Rosenow, C., P. Ryan, J. N. Weiser, S. Johnson, P. Fontan, A. Ortqvist, and H. R. Masure. 1997. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol. Microbiol. 25 : 819-829.
21.
Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22.
Severin, A., D. Horne, and A. Tomasz. 1997. Autolysis and cell wall degradation in a choline-independent strain of Streptococcus pneumoniae. Microb. Drug Resist. 3 : 391-400.
23.
Song, J.-H., K. S. Ko, L.-Y. Lee, J. Y. Baek, W. S. Oh, H. S. Yoon, J.-Y. Jeong, and J. Chun. 2005. Identification of essential genes in Streptococcus pneumoniae by allelic replacement mutagenesis. Mol. Cells 19 : 365-374.
24.
Tatusov, R. L., E. V. Koonin, and D. J. Lipman. 1997. A genomic perspective on protein families. Science 278 : 631-637.
25.
Tomasz, A. 1967. Choline in the cell wall of a bacterium: novel type of polymer-linked choline in Pneumococcus. Science 157 : 694-697.
26.
Tomasz, A. 1964. Studies on the competence (for genetic transformation) of Diplococcus pneumoniae in a synthetic medium, abstr. G87. Abstr. 64th Gen. Meet. Am. Soc. Microbiol. American Society for Microbiology, Washington, DC.
27.
Tomasz, A., and R. D. Hotchkiss. 1964. Regulation of the transformability of the pneumococcal cultures by macromolecular cell products. Proc. Natl. Acad. Sci. USA 51 : 480-487.
28.
Yother, J., K. Leopold, J. White, and W. Fischer. 1998. Generation and properties of a Streptococcus pneumoniae mutant which does not require choline or analogs for growth. J. Bacteriol. 180 : 2093-2101.
29.
Yother, J., and J. M. White. 1994. Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J. Bacteriol. 176 : 2976-2985.
30.
Zhang, J. R., I. Idanpaan-Heikkila, W. Fischer, and E. I. Tuomanen. 1999. Pneumococcal licD2 gene is involved in phosphorylcholine metabolism. Mol. Microbiol. 31 : 1477-1488.

Information & Contributors

Information

Published In

cover image Journal of Bacteriology
Journal of Bacteriology
Volume 189Number 191 October 2007
Pages: 7105 - 7111
PubMed: 17660291

History

Received: 1 May 2007
Accepted: 12 July 2007
Published online: 1 October 2007

Permissions

Request permissions for this article.

Contributors

Authors

Marlen Damjanovic
Microbial Genetics, University of Tübingen, Tübingen, Germany
Present address: Departement für Innere Medizin, Universitätsspital Zürich, Zürich, Switzerland.; § Present address: Department of Biotechnology, Babasaheb Ambedkar Marathwada University, Osmanabad, Maharashtra, India.
Arun S. Kharat
Laboratory of Microbiology, The Rockefeller University, New York, New York
Present address: Departement für Innere Medizin, Universitätsspital Zürich, Zürich, Switzerland.; § Present address: Department of Biotechnology, Babasaheb Ambedkar Marathwada University, Osmanabad, Maharashtra, India.
Alice Eberhardt
Institute for Cell and Molecular Biosciences, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom
Alexander Tomasz
Laboratory of Microbiology, The Rockefeller University, New York, New York
Waldemar Vollmer [email protected]
Microbial Genetics, University of Tübingen, Tübingen, Germany
Institute for Cell and Molecular Biosciences, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy